Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)

Active
Yes
Status
Open
Release Date
April 23rd, 2024
Open Date
July 21st, 2024
Due Date(s)
August 21st, 2024
Close Date
August 22nd, 2024
Topic No.
RFA-CA-24-023

Topic

Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: STTRPhase: Phase IYear: 2024

Summary

The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Small Business Transition Grant for Early Career Scientists. This grant aims to support early-career academic scientists interested in transitioning to entrepreneurship while also facilitating the transfer of technology from academic laboratories into small businesses. The eligibility for this grant is limited to applicants with 10 years or less of post-graduate experience. The grant allows for Phase I only Small Business Technology Transfer (STTR) applications, as well as Fast-Track applications that transition from Phase I STTR to Phase II Small Business Innovation Research (SBIR). The Phase I STTR allows for more work to be completed at the university and provides flexibility in terms of principal investigator (PI) employment. Upon successful completion of Phase I, fast-track applications transition to Phase II as an SBIR award, requiring the PI to move their employment to the small business and limiting university involvement. Mentoring is a crucial component of this grant, and a mentoring plan is required in the application. The ideal candidate for this grant is a postdoctoral researcher who has participated in technology discovery during their academic work and is ready to move to a small business with the support of an experienced team. Proposed projects must pertain to the mission space of one of the participating Institutes, including the National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Human Genome Research Institute, and National Institute of Mental Health. Each Institute has specific areas of research interest, and applicants are encouraged to contact the Scientific/Research Contacts from the respective Institutes to discuss program relevance. The grant has key requirements, including the need for strong mentors, eligibility limited to early-career scientists, and alignment with the scientific/technical scope of the participating Institutes. Additionally, there are specific requirements for each Institute, such as completion of entrepreneurship training programs. The transition from Phase I to Phase II is contingent upon meeting certain criteria, including a Phase I final progress report, an updated commercialization plan, updated IP agreements, letters of support from mentors, completion of entrepreneurship programs, and verification of SBIR eligibility. The grant provides an opportunity for early-career scientists to transition to entrepreneurship and supports the advancement of technologies from academic research laboratories to small businesses.

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Human Genome Research Institute (NHGRI), and National Institute of Mental Health (NIMH) intend to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. For the purposes of this funding announcement, eligibility as an early career scientist is limited to applicants with 10 years, or less, of post-graduate experience.

This NOFO allows for Phase I only STTR applications, and Fast-Track applications that use a unique award structure comprised of a Phase I STTR that transitions to a Phase II SBIR. Only small businesses can apply for and receive SBIR or STTR awards. However, this RFA utilizes an STTR in Phase I because the STTR program is intended for projects in which the awardee small business is working closely with a university and therefore allows more work to be completed at the university as well as allowing more flexibility in terms of PI employment. Awards made under this NOFO will begin as a Phase I STTR to allow the early career scientist PI, or candidate, complete proof of concept studies at the academic site and prepare the technology to move into the small business. Upon successful completion of the STTR Phase I activities, applications submitted as a fast-track award will transition to Phase II as an SBIR award, requiring the PI to move their place of employment to the small business and limiting university involvement.

Mentoring is a key component of Small Business Transition Grant awards. Traditionally, mentoring has not been a factor in SBIR/STTR funding decisions, however, because mentoring is critical to facilitate the transition from junior academic scientist to entrepreneur, a mentoring plan is required in the application and included in the peer review scoring criteria for this NOFO. The ideal candidate for a Small Business Transition Grant award is a postdoctoral researcher who participated in technology discovery during their academic work and is now ready to move to a small business with the support of an experienced team to advise them.

To be responsive to this NOFO, proposed projects MUST pertain to the mission space of one of the participating Institutes and propose the development of a technology that fits into the technology categories described below under additional Institute/Center Priorities. Furthermore, all proposals must include clear, quantitative milestones (i.e. a quantitative definition of success) for each aim. In some cases, additional milestones or timelines may be requested as part of the Just In Time process or post-award. For awards made under this NOFO, transition from Phase I to Phase II will only occur after demonstration that all the following criteria have been met; the candidate continues to receive mentoring support by both technical and business development (BD) mentors, all necessary IP agreement(s) are updated to reflect the next award phase timeline, a demonstration that all Phase I technical milestones have been achieved (more information under Section IV. Application Submission Information).

Background and Rationale Academic laboratories are critical partners for U.S. small businesses that are supported by the NIH SBIR/STTR Programs. These academic laboratories fulfill many roles, including both as the technology originators and collaborators of U.S. small businesses. This NOFO was developed, with the participation of multiple NIH ICs, to support a changing landscape of entrepreneurship where universities are increasingly encouraging junior scientists to become entrepreneurs.

IC Specific Areas of Research Interest

Specific Areas of Research Interest from the participating NIH ICs of this NOFO are listed below. Applicants are strongly encouraged to contact the Scientific/Research Contacts from various NIH ICs listed in Section VII prior to submission to discuss IC program relevance.

National Cancer Institute (NCI): The National Cancer Institute (NCI) SBIR/STTR programs support the development, translation, and commercialization of novel therapeutics, devices, diagnostics, and processes that are aimed at reducing the burden of cancer. A retrospective economic impact analysis of NCI SBIR/STTR Phase II grants from 1998-2010 indicated there was a substantial rate of commercialization, with 247 products commercialized from 690 Phase II grants. Sales of products and services associated with these grants were reported at $9.1 billion. Based on the reported sales, economic modeling calculated that over 107,000 jobs were created and $26.2 billion of economic output was produced.

National Institute of Biomedical Imaging and Bioengineering (NIBIB): The Small Business program at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is used to achieve the mission of the institute by supporting innovative technologies through various stages of commercial research and development. The NIBIB welcomes SBIR and STTR applications from small businesses proposing ideas relevant to its scientific program areas. Please contact program staff if you have questions about which institutes(s) would be the best fit for your technology.

National Human Genome Research Institute (NHGRI): The National Human Genome Research Institute (NHGRI) strives to improve the health of all humans through advances in genomics research. The NHGRI Small Business Program encourages research and development applications with commercial potential that are comprehensive across the genome or are generalizable across variants, tissues, diseases or functions.

National Institute of Mental Health (NIMH): The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. The goal of the NIMH SBIR and STTR programs is to support small businesses to develop technologies that can advance the mission of the institute.

Institute/Center Priorities National Cancer Institute (NCI)

NCI encourages proposals that fall into several technology areas, including; (1) Cancer Therapeutics and Preventative Agents; (2) Cancer Imaging Technologies, Interventional Devices, and In Vivo Diagnostics; (3) In Vitro and Ex Vivo Cancer Diagnostics and Prognostics; or (4) Technologies for Cancer Prevention and Control, Supportive Care, and Survivorship.

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

The NIBIB is interested in the above topics for this NOFO as they pertain to NIBIB mission. NIBIB interests include the development and integration of advanced bioengineering, sensing, imaging, and computational technologies for the improvement of human health and medical care. An application is not within the NIBIB mission if its principal focus is the development of a technology with the goal of understanding basic biological functions or pathological mechanisms. Additionally, NIBIB only supports projects developing platform technologies that are applicable to a broad spectrum of disorders and diseases. However, applicants may propose research that utilizes only a single tissue, organ, or physiological condition as a model system to facilitate the development of what is expected to be a more broadly applicable enabling technology. Potential applicants are encouraged to send a draft specific aims page to the NIBIB Small Business Program (NIBIB-SBIR@mail.nih.gov) to determine if their research fits within the NIBIB mission.

National Human Genome Research Institute (NHGRI)

NHGRI priority areas are described in the NHGRI 2020 Strategic Vision and generally fall into one or more of the following research areas: 1) Genomic Technology Development; 2) Genome Structure and Function; 3) Computational Genomics; 4) Genomic Variation, Population Genomics and Disease; 5) Clinical Genomics and Sequencing; 6) Genomic Medicine Implementation and Evaluation; 7) Ethical, Legal, and Social Implications of Genomics; and 8) Genomics Training and Education.

National Institute of Mental Health (NIMH)

NIMH is interested in projects that fall within our program priorities: https://www.nimh.nih.gov/funding/sbir/nimh-sbir-sttr-program-priorities.

Research Objectives and Requirements Objectives of this NOFO

This NOFO has two simultaneous objectives; (1) to support the transition of early-career scientists from academia to entrepreneurship, and (2) to support the advancement of technologies out of academic research laboratories into small U.S. businesses.

Key Requirements for this NOFO

A. Requirement for strong mentors

Mentoring is a key component of this NOFO, and review of the mentors and mentoring plan is included in the scored peer review criteria. While candidates must have independent oversight over the project, each proposal must identify at least two mentors, one mentor who will advise the candidate on technology development, and one mentor who will advise the candidate on business development. More specifically, the purpose of the technical mentor is to help the candidate devise the best technical path forward by providing feedback on the appropriate assays and models to reach each developmental milestone. The purpose of the business development mentor is to help the candidate maintain a milestone-driven R&D plan and advise the candidate on which R&D milestones are appropriate for commercial development. Each mentor must provide a letter of support that outlines their commitment to the development of the technology and to the candidate. The identified mentors must meet the following criteria:

Technical mentor: The technical mentor should be the head of the academic laboratory from where the technology originated or be recognized as a key opinion leader in the same field as the technology being developed. This person may also be a co-founder, owner, or a C-level executive in the small business.

Business Development (BD) Mentor: The BD mentor could be an experienced BD executive, an experienced entrepreneur, an employee of a university’s technology transfer/innovation office, or an entrepreneur-in-residence (EIR). The BD mentor must have experience in an appropriate biotech sector relevant to the technology under development and should have experience as an executive in an industry setting or experience mentoring startups. Ideally, a BD mentor would have a track record of mentoring emerging entrepreneurs.

Other mentors: Applicants can include, but are not required to include, additional mentors or mentoring teams that will help them identify appropriate milestones and/or development strategy. The application must describe how each mentor will contribute to the success of the candidate and the success of the technology.

B. Eligibility

The purpose of the Small Business Transition Grant is to support early-career scientists who are transitioning from an academic research setting to a small business. Therefore, eligibility is limited to early-career scientists. For more information on who qualifies as an early career scientist, see eligibility in section III below.

C. Scientific/Technical Scope

Applications will be considered if they are within the mission of one of the participating Organizations/Institutes as described above under "Additional Institute/Center Priorities."

Additional Institute/Center Requirements National Institute of Mental Health (NIMH)

Potential applicants should reach out to NIMH before submitting an application. Each grant awarded through NIMH will be required to complete either the C3i Program: https://www.nibib.nih.gov/research-funding/concept-clinic-commercializing-innovation-c3i-program/c3i-validationexecution or the I-Corps program at NIH: https://sbir.cancer.gov/commercialization/business/icorps..

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Each grant awarded through NIBIB will be required to completed one of the two C3i programs at NIH (https://www.nibib.nih.gov/research-program/c3i-program). The NIH C3i program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). There are two versions of this program, the educational C3i (eC3i) program is a 10-week virtual program, which the C3i Validation/Execution program is a 24-week in-depth commercialization course. Both programs require 10 hours of work each week divided by the team members.

In some circumstances when the project team has already completed a non-NIH entrepreneur training program prior to award, the project teams may be given an exemption from the NIH C3i program requirement. An exemption request must be submitted in writing to the NIBIB small business office (NIBIB-SBIR@mail.nih.gov). Exemptions will only be considered for awardees and will not be considered prior to application submission. Exemptions from NIH C3i program are case by case and are not guaranteed even if the project team has previously completed an entrepreneur training program.

Evaluation of Transitioning from Phase I to Phase II The transition from Phase I to Phase II will only occur after the following criteria are met and documentation approved by a transition committee coordinated by the funding IC; (1) a Phase I final progress report that includes a description of the Phase I success criteria and a demonstration that the success criteria were met, as well as a description of key learnings experiences of the Candidate (see description below); (2) an updated commercialization plan that identifies changes from the original commercialization plan including changes based on learnings from I-Corps at NIH or C3i program as well as other entrepreneurial activities and events; (3) an updated IP agreement and an updated letter of support from the university that describes the current status of the IP, e.g. license option extension or executed license, etc., the metrics that the university used to evaluate the IP and verification that the university continues to support the small businesses efforts to develop and commercialize the technology; (4) updated letters of support from the technology mentor and BD mentor that describe the professional growth of the Candidate during the Phase I project period, and a description of the mentoring relationship in Phase II based on the needs of the Candidate; (5) full participation and completion of I-Corps at NIH or C3i program, unless exempted in writing from their program officer; (6) Verification that all SBIR eligibility requirements are met as all awards must transition to SBIR in Phase II (see below for SBIR eligibility criteria). Because of the dual focus on mentoring and product development, it is expected that the Phase I portion of several applications may propose fairly high-risk activities. While high-risk activities are allowed in Phase I, transition to Phase II is dependent upon demonstrating adequate technical success in Phase I, projects that fail to meet their success criteria or do not demonstrate adequate technical progress in Phase I as determined by the transition committee, will not transition to Phase II.

Similar Opportunities

Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed). This grant aims to support early-career scientists and health professionals interested in transitioning to a small business to gain industry experience, receive entrepreneurial training and mentorship, and advance biomedical technology with commercial potential. The grant will provide funding for research and development efforts, as well as the employment and salaries of researchers as Program Directors/Principal Investigators overseeing the supported research project. The grant also emphasizes the importance of mentorship and entrepreneurship training, with applicants required to identify at least one mentor and develop a career development plan for the PD/PI. The grant is open for applications until April 6, 2027, and more information can be found on the grants.gov website.
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed). This grant aims to support early-career scientists and health professionals interested in transitioning to a small business to gain industry experience, receive entrepreneurial training and mentorship, and advance biomedical or public health technology with commercial potential. The grant utilizes the R43/R44 SBIR Award mechanism and supports research and development efforts, as well as the employment and salaries of researchers as Program Directors/Principal Investigators overseeing the project. The grant encourages the inclusion of mentors with extensive entrepreneurial and mentorship experience and requires a career development plan for the PD/PI that includes entrepreneurship training. The eligibility of the contact PD/PI is limited to scientists, engineers, and health professionals who are new to research entrepreneurship and have not independently led significant research programs. The proposed projects must pertain to the mission space of one of the participating Institutes and Centers and fall within the scope of the traditional SBIR/STTR grant mechanisms. The grant is open for applications until April 6, 2027, and more information can be found on the grants.gov website.
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required). This grant aims to support early-career scientists and health professionals interested in transitioning to a small business to gain industry experience, receive entrepreneurial training and mentorship, and advance biomedical or public health technology with commercial potential. The grant utilizes the R43/R44 SBIR Award mechanism and supports research and development efforts, as well as the employment and salaries of researchers as Program Directors/Principal Investigators overseeing the project. The grant requires the inclusion of at least one mentor and a career development plan for the PD/PI, which may include entrepreneurship training. The eligibility of the contact PD/PI is limited to scientists, engineers, and health professionals who are new to research entrepreneurship and have not independently led significant research programs. The proposed projects must pertain to the mission space of one of the participating Institutes and Centers and fall within the scope of the traditional SBIR/STTR grant mechanisms. The grant supports Phase I and Fast-Track applications and encourages diversity in the biomedical entrepreneurial workforce. The specific research priorities and areas of interest vary among the participating Institutes and Centers, such as the National Center for Complementary and Integrative Health, National Eye Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, and others. The grant is currently open for applications, with multiple application due dates throughout the year. More information and the full solicitation can be found at the provided links.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).